Regulatory Affairs Updates
Discover the latest news in Regulatory Affairs
MDCG 2024-1-5 – Urogynaecological Surgical Mesh Implants used for Pelvic Organ Prolapse repair and Stress Urinary Incontinence
- Kirsten Van Garsse, Authorized Representative Director & Regulatory Affairs Manager
![MDCG 2024-1-5 – Urogynaecological Surgical Mesh Implants used for Pelvic Organ Prolapse repair and Stress Urinary Incontinence](https://qbdgroup.com/wp-content/uploads/Image-blogRegulatory-update-website-5.png)
The aim of this Device Specific Vigilance Guidance (DSVG) is to harmonise vigilance reporting and provide guidance for manufacturers of Urogynaecological Surgical Mesh Implants used for Pelvic Organ Prolapse repair and Stress Urinary Incontinence. It provides further clarification for vigilance reporting of Urogynaecological Surgical Mesh Implants used for Pelvic Organ Prolapse repair and Stress Urinary Incontinence to the relevant Competent Authority and should be read in conjunction with the requirements of Regulation (EU) 2017/745 on medical devices (MDR). The DSVG does not replace or extend any of the requirements in the MDR, it simply outlines the way to report incidents and serious incidents which occurred with Urogynaecological Surgical Mesh Implants used for Pelvic Organ Prolapse repair and Stress Urinary Incontinence to the relevant Competent Authority.
Get in touch with our experts
Did you find this article interesting? Thanks for sharing it with your network:
Here you find all news related to Regulatory Affairs